Xu X, Xu D, Zhou X, Huang J, Gu S, Zhang Z
Nat Commun. 2025; 16(1):1747.
PMID: 39966460
PMC: 11836052.
DOI: 10.1038/s41467-025-57084-2.
Dalimunthe A, Carensia Gunawan M, Dhiya Utari Z, Dinata M, Halim P, Estherina S Pakpahan N
Front Pharmacol. 2024; 15:1461478.
PMID: 39605919
PMC: 11598436.
DOI: 10.3389/fphar.2024.1461478.
Sato Y, Kondo H, Sato Y, Abe A, Kikuchi M, Sato T
Pharmaceutics. 2024; 16(9).
PMID: 39339175
PMC: 11435224.
DOI: 10.3390/pharmaceutics16091138.
De Rosa F, Giannatiempo B, Charlier B, Coglianese A, Mensitieri F, Gaudino G
Pharmaceutics. 2023; 15(8).
PMID: 37631302
PMC: 10457775.
DOI: 10.3390/pharmaceutics15082088.
Hirasawa T, Kikuchi M, Takasaki S, Kumondai M, Sato Y, Sato T
Heliyon. 2023; 9(6):e16926.
PMID: 37484337
PMC: 10360929.
DOI: 10.1016/j.heliyon.2023.e16926.
Recommendations for the measurement of sexual steroids. A step forward in the silent revolution of mass spectrometry.
Lopez Hellin J
Adv Lab Med. 2023; 4(1):1-4.
PMID: 37359896
PMC: 10197180.
DOI: 10.1515/almed-2023-0022.
Artificial Intelligence and Machine Learning Approaches to Facilitate Therapeutic Drug Management and Model-Informed Precision Dosing.
Poweleit E, Vinks A, Mizuno T
Ther Drug Monit. 2023; 45(2):143-150.
PMID: 36750470
PMC: 10378651.
DOI: 10.1097/FTD.0000000000001078.
Liquid chromatography-tandem mass spectrometry for clinical diagnostics.
Thomas S, French D, Jannetto P, Rappold B, Clarke W
Nat Rev Methods Primers. 2022; 2(1):96.
PMID: 36532107
PMC: 9735147.
DOI: 10.1038/s43586-022-00175-x.
Comparison of LC-MS/MS and EMIT methods for the precise determination of blood sirolimus in children with vascular anomalies.
Zhao Y, Dai H, Li Y, Zhang Y, Guo H, Ding X
Front Pharmacol. 2022; 13:925018.
PMID: 36147342
PMC: 9486013.
DOI: 10.3389/fphar.2022.925018.
Simultaneous LC-ESI-MS/MS Quantification of Levosimendan and Its Metabolites for Therapeutic Drug Monitoring of Cardiac Surgery Patients.
Kipka H, Tomasi R, Hubner M, Liebchen U, Hagl C, Wanner K
Pharmaceutics. 2022; 14(7).
PMID: 35890349
PMC: 9319272.
DOI: 10.3390/pharmaceutics14071454.
Quantification and Determination of Stability of Tylvalosin in Pig Plasma by Ultra-High Liquid Chromatography with Ultraviolet Detection.
Hernandis V, Escudero E, Galecio J, Marin P
Animals (Basel). 2022; 12(11).
PMID: 35681849
PMC: 9179391.
DOI: 10.3390/ani12111385.
Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs.
Kuhlin J, Sturkenboom M, Ghimire S, Margineanu I, van den Elsen S, Simbar N
Clin Mass Spectrom. 2021; 14 Pt A:34-45.
PMID: 34934812
PMC: 8653513.
DOI: 10.1016/j.clinms.2018.10.002.
A semi-automated, isotope-dilution high-resolution mass spectrometry assay for therapeutic drug monitoring of antidepressants.
Lindner J, Vogeser M, Sorg K, Grimm S
Clin Mass Spectrom. 2021; 14 Pt B:89-98.
PMID: 34917765
PMC: 8669456.
DOI: 10.1016/j.clinms.2019.05.004.
Validation of a novel UPLC-HRMS method for human whole-blood cyclosporine and comparison with a CMIA immunoassay.
Wang X, Qin W, Chen W, Liu H, Zhang D, Zhang X
Exp Ther Med. 2021; 21(3):191.
PMID: 33488800
PMC: 7812591.
DOI: 10.3892/etm.2021.9623.
Direct and Precise Measurement of Bevacizumab Levels in Human Plasma Based on Controlled Methionine Oxidation and Multiple Reaction Monitoring.
Gaspar V, Ibrahim S, Sobsey C, Richard V, Spatz A, Zahedi R
ACS Pharmacol Transl Sci. 2020; 3(6):1304-1309.
PMID: 33344903
PMC: 7737317.
DOI: 10.1021/acsptsci.0c00134.
Development of a methodology to make individual estimates of the precision of liquid chromatography-tandem mass spectrometry drug assay results for use in population pharmacokinetic modeling and the optimization of dosage regimens.
Karvaly G, Neely M, Kovacs K, Vincze I, Vasarhelyi B, Jelliffe R
PLoS One. 2020; 15(3):e0229873.
PMID: 32134971
PMC: 7058336.
DOI: 10.1371/journal.pone.0229873.
Measurement of caffeine and its three primary metabolites in human plasma by HPLC-ESI-MS/MS and clinical application.
Chen F, Hu Z, Parker R, Laizure S
Biomed Chromatogr. 2016; 31(6).
PMID: 27864843
PMC: 5415443.
DOI: 10.1002/bmc.3900.
